Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Research shows treating HIV-AIDS with interleukin-2 is ineffective

20.10.2009
A team of researchers at the MUHC/McGill and their international colleagues recommend halting all clinical trials on interleukin-2.

An international research team has demonstrated that treating HIV-AIDS with interleukin-2 (IL-2) is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped. Their finding was published in the New England Journal of Medicine in an article co-authored by 14 researchers, including Dr. Jean-Pierre Routy of the Research Institute of the McGill University Health Centre (RI-MUHC).

IL-2 is currently used as a complement to highly active antiretroviral therapy (known as HAART), which is administered to patients with HIV-AIDS. Since HAART controls replication of viruses in the blood, doctors thought that IL-2 would help regenerate more CD4+ immune cells, which serve as an indicator of viral progression. It was thought that IL-2 increased the natural immunity of patients by helping immune cells mature and multiply.

“Our results show that IL-2 has no effect on the development of AIDS or on patient survival,” says Dr. Routy. “More precisely, while the presence of IL-2 leads to a faster increase of CD4+ immune cells, these cells are less functional than the CD4+ cells that regenerate naturally in patients who do not receive IL-2. This means that IL-2 treatment provides no benefit and does not prevent AIDS-related infectious diseases.”

“For the first time, a study has shed light on recurring questions concerning the value of biological markers and their limitations in assessing patient health,” explains Dr. Routy. “Our challenge now will be to develop tests that assess the function of immune cells and not simply their quantity. This will ensure that HIV treatments indeed have a clinical benefit for patients.”

This 8-year study involved over 5000 patients in 25 countries, and was one of the largest ever conducted on HIV-AIDS. “The fact that data from developing countries was used in biomedical research on innovative compounds is very revolutionary in the history of HIV-AIDS research,” explains Dr. Routy.

Dr. Jean-Pierre Routy is a physician in the Division of Hematology and Immunodeficiency at the MUHC as well as a researcher in the Infection and Immunity Axis at the Research Institute of the MUHC. He is also an Associate Professor of Hematology at McGill University and a senior clinical researcher with the Fonds de la recherche en santé du Québec (FRSQ).

Funding
This study was funded by a grant from the National Institutes of Health (NIH)
Partners
This article was co-authored by Dr. D. Abrams, University of California, San Francisco; Dr. Y. Lévy, INSERM U955, Université Paris 12, et Assistance Publique-Hôpitaux de Paris, Groupe Henri-Mondor Albert-Chenevier, Dr. M.H. Losso, Hospital General de Agudos, Dr. J.M. Ramos Mejia, Buenos Aires; Dr. A. Babiker, Medical Research Council, London; Dr. G. Collins, University of Minnesota, Minneapolis; Dr. D. Cooper, National Centre in HIV Epidemiology and Clinical Research, Sydney; Dr. J. Darbyshire, Medical Research Council, London; Dr. S. Emery, National Centre in HIV Epidemiology and Clinical Research, Sydney; Dr. L. Fox, National Institute of Allergy and Infectious Diseases, Bethesda; Dr. F. Gordin, Washington Veterans Medical Center, Washington, DC; Dr. H.C. Lane, National Institutes of Health, Bethesda; Dr. J.D. Lundgren, Rigshospitalet & University of Copenhagen, Copenhagen; Dr. R. Mitsuyasu, University of California, Los Angeles; Dr. J.D. Neaton, University of Minnesota, Minneapolis; Dr. A. Phillips, University College London Medical School, London; Dr. J.P Routy, Royal Victoria Hospital, McGill University Health Centre; Dr. G. Tambussi, Fondazione San Raffaele del Monte Tabor, Milano; Dr. D. Wentworth, University of Minnesota, Minneapolis.

The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, the university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 600 researchers, nearly 1200 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge.

The Research Institute of the MUHC is supported in part by the Fonds de la recherche en santé du Québec. For further details visit: www.muhc.ca/research

You will find this press release, with the original article and a short audio interview by following this link:http://www.muhc.ca/media/news/

For more information please contact:

Julie Robert
Communications Coordinator (research)
MUHC Public Affairs & Strategic Planning
(514) 843 1560
julie.robert@muhc.mcgill.ca

Julie Robert | EurekAlert!
Further information:
http://www.muhc.ca/media/news/
http://www.muhc.mcgill.ca

More articles from Health and Medicine:

nachricht Second cause of hidden hearing loss identified
20.02.2017 | Michigan Medicine - University of Michigan

nachricht Prospect for more effective treatment of nerve pain
20.02.2017 | Universität Zürich

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Switched-on DNA

20.02.2017 | Materials Sciences

Second cause of hidden hearing loss identified

20.02.2017 | Health and Medicine

Prospect for more effective treatment of nerve pain

20.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>